SCHEMBL19964863

SCHEMBL19964863

CCOC(=O)c1cc2c(-c3ccn[nH]3)ccn2c(N(C)C2CCN(CC(F)(F)F)CC2)c1C

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EED O75530 10/20 0.45
RBBP4 Q09028 10/20 0.45
SUZ12 Q15022 10/20 0.45
EZH2 Q15910 10/20 0.45
AEBP2 Q6ZN18 10/20 0.45
IDH1 O75874 1/20 0.36
ABL1 P00519 2/20 0.34
JMJD6 Q6NYC1 1/20 0.34
LTA4H P09960 3/20 0.33
METAP2 P50579 1/20 0.33
CDC7 O00311 1/20 0.33
PIM1 P11309 1/20 0.33
CLK1 P49759 1/20 0.33
CLK2 P49760 1/20 0.33
GSK3A P49840 1/20 0.33
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19964867 0.91 EED (0.45) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL19964871 0.86 JMJD6 (0.37) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL28958927 0.86 EED (0.37) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL21157379 0.84 EZH2 (0.37) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL19964922 0.80 EZH2 (0.73) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL21113463 0.78 EED (0.35) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL19964715 0.77 EZH2 (0.37) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL28886599 0.76 EED (0.36) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL21251371 0.71 EED (0.56) EEDRBBP4SUZ12EZH2AEBP2
SCHEMBL19964973 0.68 HPGDS (0.35) EZH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof SHANGHAI HAIHE PHARMACEUTICAL CO., LTD. (CN) 2021-04-06 US disclosed
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof SHANGHAI HAIHE PHARMACEUTICAL CO., LTD. (CN) 2021-04-06 US disclosed
EP-3524602-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Haihe Pharmaceutical Co., Ltd. (CN) 2019-08-14 EP disclosed
EP-3524602-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Haihe Pharmaceutical Co., Ltd. (CN) 2019-08-14 EP disclosed
US-20190211010-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF HAIHE BIOPHARMA CO. LTD. (CN) 2019-07-11 US disclosed
US-20190211010-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF HAIHE BIOPHARMA CO. LTD. (CN) 2019-07-11 US disclosed
WO-2018045971-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 上海海和药物研究开发有限公司 2018-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10968215-B2 Pyrido five-element aromatic ring compound, preparation method therefor and use thereof EZH2, IKZF2, SUZ12 EED 41/4885RBBP4 288/4885SUZ12 3/4885
US-20190211010-A1 PYRIDO FIVE-ELEMENT AROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF EZH2, IKZF2, SUZ12 EED 41/4885RBBP4 288/4885SUZ12 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.